Startup Dossier
DiogenX
Traitement first-in-class du diabète notamment de type 1
active
Typestartup
SectorBioTech
LocationMarseille
About
Traitement first-in-class du diabète notamment de type 1
Structural DNA
Legal Name
DiogenX
SIREN
881305544
Founders & Team
Funding Lineage
Series A
AdBio partners (Lead)
€34.0M
May 2023
Series A
Omnes Capital (Lead)
€27.5M
May 2023
Programs
i-Lab
2021Pharmacie & biotechnologies